Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Apixmed logo — Advanced medical data analysis for personalized treatment

Apixmed

Advanced medical data analysis for personalized treatment

Founded 2023 3 employees

General Information

Company Name Apixmed
Founded Year 2023
Employees 3
Social

Get notified when Apixmed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Apixmed

Apixmed is a revolutionary startup that is set to redefine the future of healthcare with its advanced medical data analysis for personalized treatment. The company's slogan, "Advanced medical data analysis for personalized treatment," reflects its core focus on leveraging cutting-edge technology to transform disease treatment into a truly personalized and precise experience. Apixmed's core offerings include precision diagnostics with DNA analysis, optimizing drug responses, preventing related conditions, and providing timely cautions and warnings. These innovative solutions are driven by the integration of AI virtual assistant technology, positioning the company at the forefront of a groundbreaking medical revolution. Founded in 2023, Apixmed is driven by a passion for transforming the quality of healthcare through technology. While specific details on industries, headquarters, last investment, and last investment investors are not currently available, the company's bold vision and commitment to redefining the future of healthcare make it an intriguing prospect for potential investors. In a rapidly evolving healthcare landscape, Apixmed's focus on personalized disease treatment and the integration of AI technologies presents a compelling investment opportunity. The company's potential to create significant impact in the healthcare industry by leveraging advanced data analysis and AI-driven solutions positions it as a promising contender in the startup ecosystem. As the demand for personalized healthcare solutions continues to grow, Apixmed's innovative approach holds promise for both industry disruption and investor interest.

Taxonomy: medical data analysis, personalized treatment, virtual assistant, precision diagnostics, DNA analysis, drug optimization, disease treatment, personalized medicine, medical revolution

No funding data available for Apixmed yet.

Get notified when Apixmed raises funding

Apixmed Alternatives & Competitors

Apixmed vs
Sherpa
Sherpa The Netherlands

On a mission to support personalized treatment by remote monitoring of neurological diseases

3 employees
Health Care, Medical Devices
Apixmed vs
Adamant Health
Adamant Health Finland

Revolutionizing the care of Parkinson’s disease.

Seed
26 employees
Health Care, Medical Devices
Apixmed vs
Personalized Hematology-Oncology of Wake Forest, PLLC
Personalized Hematology-Oncology of Wake Forest, PLLC United States

Independent clinic that focus on personalized cancer treatment and certified infusion center for any...

6 employees
Care Economy, Health Care

FAQ About Apixmed

Advanced medical data analysis for personalized treatment
Apixmed was founded in 2023.
Apixmed has approximately 3 employees.
Top alternatives and competitors to Apixmed include Sherpa, Adamant Health, Personalized Hematology-Oncology of Wake Forest, PLLC, ImpriMed, Inc., Bredis Healthcare Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Apixmed and Sherpa are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Apixmed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy